Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Segawa · SciRah

Researcher profile · Semantic Scholar

Y. Segawa

Share profile

Y. Segawa — researcher profile on SciRah

h-index: 33
Works: 136
Citations: 3,497

Most-cited papers

Focal ground-glass opacity detected by low-dose helical CT.
M. Nakata, H. Saeki, I. Takata, Y. Segawa +3 more
2002Chest288 citations
Semantic Scholar
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Y. Segawa, K. Kiura, N. Takigawa, H. Kamei +16 more
2010Journal of Clinical Oncology230 citations
Semantic Scholar
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.
K. Kubota, Koshiro Watanabe, H. Kunitoh, K. Noda +15 more
2004Journal of Clinical Oncology223 citations Open access
Semantic Scholar
Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis
I. Sekine, Y. Segawa, K. Kubota, T. Saeki
2013Cancer Science166 citations Open access
Semantic Scholar
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group.
S. Umemura, K. Tsubouchi, H. Yoshioka, K. Hotta +10 more
2012Lung Cancer128 citations
Semantic Scholar
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
H. Hayashi, Y. Takiguchi, H. Minami, K. Akiyoshi +16 more
2020JAMA Oncology100 citations Open access
Semantic Scholar
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
K. Shitara, K. Muro, Y. Shimada, S. Hironaka +19 more
2016Gastric Cancer80 citations Open access
Semantic Scholar
A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705
H. Yoshioka, K. Hotta, K. Kiura, N. Takigawa +9 more
2010Journal of Thoracic Oncology78 citations Open access
Semantic Scholar
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
N. Seki, T. Takasu, K. Mandai, M. Nakata +6 more
2002Clinical Cancer Research74 citations
Semantic Scholar
Open-Label Phase II Study of the Efficacy of Nivolumab for Cancer of Unknown Primary.
J. Tanizaki, K. Yonemori, K. Akiyoshi, H. Minami +14 more
2021Annals of Oncology68 citations Open access
Semantic Scholar
Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience
K. Hotta, K. Kiura, N. Takigawa, H. Yoshioka +16 more
2010Journal of Thoracic Oncology68 citations Open access
Semantic Scholar
Parathyroid hormone‐related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia
A. Hiraki, H. Ueoka, A. Bessho, Y. Segawa +6 more
2002Cancer66 citations
Semantic Scholar
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition.
S. Sawada, E. Komori, N. Nogami, A. Bessho +4 more
2005Chest63 citations
Semantic Scholar
Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
K. Kiura, H. Ueoka, Y. Segawa, M. Tabata +12 more
2003British Journal of Cancer62 citations Open access
Semantic Scholar
Impact of HER2 Gene and Protein Status on the Treatment Outcome of Cisplatin-Based Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer
S. Kuyama, K. Hotta, M. Tabata, Y. Segawa +6 more
2008Journal of Thoracic Oncology55 citations Open access
Semantic Scholar
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy.
M. Maemondo, N. Masuda, I. Sekine, K. Kubota +6 more
2009Annals of Oncology54 citations Open access
Semantic Scholar
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination.
S. Sawada, E. Komori, N. Nogami, Y. Segawa +2 more
2009Lung Cancer54 citations
Semantic Scholar
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
T. Masuishi, A. Tsuji, M. Kotaka, Masato Nakamura +17 more
2020British Journal of Cancer48 citations Open access
Semantic Scholar
Hypercalcemia-leukocytosis syndrome associated with lung cancer.
A. Hiraki, H. Ueoka, I. Takata, K. Gemba +7 more
2004Lung Cancer44 citations
Semantic Scholar
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin‐Based Chemotherapy: A Subgroup Analysis of the JACCRO CC‐05/06 Trials
Y. Sunakawa, W. Ichikawa, A. Tsuji, T. Denda +14 more
2017Clinical colorectal cancer41 citations
Semantic Scholar
Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer
S. Sawada, Eisaku Komori, M. Yamashita, M. Nakata +4 more
2007Surgical Endoscopy41 citations
Semantic Scholar
Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.
Toshiaki Takahashi, N. Yamamoto, T. Nukiwa, K. Mori +10 more
2010Anticancer Research36 citations
Semantic Scholar
Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications
Y. Segawa, Saburo Takata, M. Fujii, I. Oze +9 more
2009Journal of Cancer Research and Clinical Oncology35 citations Open access
Semantic Scholar
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy.
Y. Segawa, K. Aogi, K. Inoue, M. Sano +6 more
2009Annals of Oncology34 citations Open access
Semantic Scholar
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Y. Nishimura, K. Nakagawa, K. Takeda, Masahiro Tanaka +11 more
2007International Journal of Radiation Oncology, Biology, Physics34 citations
Semantic Scholar
Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in Nonsmokers
N. Seki, S. Sawada, M. Nakata, Takeshi Inoue +4 more
2008Journal of Thoracic Oncology33 citations Open access
Semantic Scholar
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
Y. Kimura, M. Fujii, T. Masuishi, Kazuhiro Nishikawa +41 more
2017Gastric Cancer31 citations Open access
Semantic Scholar
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
N. Nogami, N. Takigawa, K. Hotta, Y. Segawa +18 more
2015Lung Cancer31 citations
Semantic Scholar
A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy.
S. Umemura, Y. Segawa, K. Fujiwara, I. Takata +4 more
2002Japanese Journal of Clinical Oncology30 citations
Semantic Scholar
Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
N. Seki, T. Takasu, S. Sawada, M. Nakata +5 more
2010Lung Cancer26 citations Open access
Semantic Scholar
Desire for Information and Involvement in Treatment Decisions: Lung Cancer Patients' Preferences and Their Physicians' Perceptions: Results from Okayama Lung Cancer Study Group Trial 0705
K. Hotta, K. Kiura, N. Takigawa, H. Yoshioka +12 more
2010Journal of Thoracic Oncology22 citations Open access
Semantic Scholar
A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503
Y. Segawa, K. Kiura, K. Hotta, N. Takigawa +9 more
2010Journal of Thoracic Oncology20 citations Open access
Semantic Scholar
Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007
N. Takigawa, K. Kiura, Y. Segawa, K. Hotta +16 more
2011Journal of Thoracic Oncology19 citations Open access
Semantic Scholar
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients
N. Takigawa, Y. Segawa, D. Kishino, K. Fujiwara +11 more
2004Cancer Chemotherapy and Pharmacology19 citations
Semantic Scholar
Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
T. Kozuki, A. Hisamoto, M. Tabata, N. Takigawa +7 more
2007Lung Cancer18 citations Open access
Semantic Scholar
STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.
Saburo Takata, N. Takigawa, Y. Segawa, T. Kubo +7 more
2012Lung Cancer17 citations
Semantic Scholar
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer
Y. Sunakawa, Dong-Yun Yang, M. Moran, S. Astrow +17 more
2016Cancer Biology & Therapy15 citations Open access
Semantic Scholar
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
K. Chikamori, D. Kishino, N. Takigawa, K. Hotta +12 more
2009Lung Cancer15 citations
Semantic Scholar
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Tsuyoshi Kodani, H. Ueoka, K. Kiura, M. Tabata +6 more
2002Lung Cancer15 citations
Semantic Scholar
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer.
T. Shibayama, K. Hotta, N. Takigawa, A. Tada +9 more
2006Lung Cancer13 citations
Semantic Scholar
Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.
M. Chikamori, N. Takigawa, K. Kiura, M. Tabata +5 more
2004Anticancer Research13 citations
Semantic Scholar
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.
Y. Segawa, H. Ueoka, K. Kiura, M. Tabata +9 more
2003Lung Cancer12 citations
Semantic Scholar
P3-148: Evaluation of efficacy and safety of erlotinib as monotherapy for Japanese patients with advanced non–small cell lung cancer (NSCLC); integrated analysis of two Japanese phase II studies
T. Tamura, Y. Nishiwaki, Koshiro Watanabe, K. Nakagawa +6 more
200710 citations Open access
Semantic Scholar
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402
N. Nogami, K. Hotta, Y. Segawa, N. Takigawa +16 more
2012Acta oncologica9 citations Open access
Semantic Scholar
NivoCUP: An open-label phase II study on the efficacy of nivolumab in cancer of unknown primary.
J. Tanizaki, K. Yonemori, K. Akiyoshi, H. Minami +13 more
20208 citations
Semantic Scholar
Phase II study of third-line cetuximab rechallenge in patients with metastatic wild-type K-RAS colorectal cancer who achieved a clinical benefit in response to first-line cetuximab plus chemotherapy (JACCRO CC-08)
A. Tsuji, T. Eto, T. Masuishi, H. Satake +16 more
20168 citations Open access
Semantic Scholar
Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience
K. Hotta, K. Kiura, N. Takigawa, S. Kuyama +14 more
2008Journal of Cancer Research and Clinical Oncology8 citations Open access
Semantic Scholar
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.
K. Hotta, N. Takigawa, K. Kiura, M. Tabata +11 more
2005Anticancer Research8 citations
Semantic Scholar
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer
Y. Sunakawa, A. Tsuji, T. Denda, Y. Segawa +13 more
2017Targeted oncology7 citations
Semantic Scholar
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer
S. Umemura, Y. Segawa, H. Ueoka, K. Hotta +6 more
2007Journal of Cancer Research and Clinical Oncology7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kiura×24
Invite
K. Kiura — researcher profile on SciRah
N. Takigawa×23
Invite
N. Takigawa — researcher profile on SciRah
M. Tanimoto×23
Invite
M. Tanimoto — researcher profile on SciRah
M. Tabata×20
Invite
M. Tabata — researcher profile on SciRah

×19

Invite

H. Ueoka — researcher profile on SciRah

Invite

K. Hotta — researcher profile on SciRah

Invite

K. Eguchi — researcher profile on SciRah

Invite

N. Nogami — researcher profile on SciRah

Invite

S. Kuyama — researcher profile on SciRah

Invite

A. Bessho — researcher profile on SciRah

Invite

T. Shinkai — researcher profile on SciRah

Invite

M. Nakata — researcher profile on SciRah